← the graveyard
Fondaparinux Sodium Injection
no longer on the FDA list · Hematology · Removed 2026-09-30
This drug was removed from the FDA's shortage list on 2026-09-30. The FDA does not say why a listing is removed. What follows is the last record we saw, from the 2026-09-29 snapshot, when its status was being discontinued. It is an archive, not current information, and it is not counted in any figure elsewhere on this site.
- Manufacturers listed (last seen)
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Machine-readable
- JSON for this drug
Presentations as last listed (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 2.5 mg/.5 mL (NDC 0781-3443-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-30 — Fondaparinux Sodium Injection was removed from the FDA list (was being discontinued)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.